This is the pre-publication version accepted by Homeopathy https://www.journals.elsevier.com/homeopathy. It is not the published version. statement.org) and recommendations of PRISMA-P checklist (http://www.prismastatement.org/documents/PRISMA-P-checklist.pdf) were utilised for the reporting of data on tables one and two. Searches were conducted in two phases. In phase one, the following electronic databases were searched: AMED, Embase, Cochrane Library, Pubmed, ScienceDirect, Elsevier Health periodicals and CORE-Hom database. In phase two, additional searches were performed through Google Scholar, Mendeley literature search and the author's university library. Citation chaining was also utilized, however studies for which the full paper or key study details could not be later established were excluded from the final systematic analysis. Searches, although wide, were limited to published, peer reviewed human trials reported in English. Key search terms were: homeopathy, upper respiratory tract infections, rhinopharyngitis and mild viral infections. Studies which included related conditions, such as bronchitis, 13 influenza, 14 otitis media and tonsillitis 15 were considered only if upper respiratory tract infection, or viral infection involving the upper respiratory tract was mentioned in the title or aims, and
Introduction
With the emergence and proliferation of multi-resistant organisms, the prospect of an 'antimicrobial perfect storm' 1 in the approaching decades has become an urgent public health concern. 1 The excessive and indiscriminate use of these drugs in both human and veterinary practices has led to the emergence and dissemination of resistant organisms that endanger their efficacy. 2, 3, 4 Each year in the United States, at least 2 million people become infected with bacteria that are resistant to antibiotics, and at least 23,000 people die as a direct result of these infections. 5 Warning of an approaching era in which antibiotics will no be longer effective, the World Health Organisation (WHO) and other agencies 6, 7 suggest alternative approaches, including the development of novel therapies to treat both mild and serious infections. 7, 8 With a growing body of clinical evidence, a strong safety record and evidence of cost-effectiveness, [9] [10] [11] homeopathy represents one potential therapeutic solution that could lead to a reduction in the use of antibiotics.
Acute upper respiratory tract infections (URTIs) account for 60% of antibiotic prescribing in primary care, 12 yet they provide little benefit for the large proportion of respiratory tract infections which are viral in origin. This review of the literature asks firstly, whether the peer review literature on this topic is sufficiently robust for homeopathy to be seriously considered as an alternative to antibiotics for upper respiratory tract infections (URTIs) and their complications and secondly, how this homeopathic intervention might take place, for example through more widespread use of particular homeopathic preparations.
Literature search strategy
The literature review focuses on peer-reviewed clinical studies featuring homeopathic treatment of upper respiratory tract infections published after 1994. Due to the close association between URTIs and acute rhino-pharyngitis and tonsillitis and their frequent treatment with antibiotics, a number of peer review studies in which homeopathy was used to treat these conditions were also reviewed. Although not rigorously following format of a systematic review, the PRISMA guidelines (http://www.prisma- 17, 18 and school. 18 The acute cough following a URTI can continue for several weeks. 13 Children are especially susceptible, and may have as many as 8 or even more episodes each year. Most URTIs are caused by a self-limiting viral illness (such as influenza and rhinoviruses) with symptoms lasting 7-10 days however complications such otitis media, 19 pharyngitis, 20 tonsillitis 21 and sinusitis 22 are frequently treated with antibiotics. [23] [24] [25] [26] [27] In the US, 23% of paediatric medical visits from 2004-8 resulted in prescriptions for antibiotics 28 with otitis media the most common reason for prescribing antibiotics in children. Other pharmacological treatments include antipyretics, anti-inflammatory drugs, expectorants, decongestants, and cough suppressants, either alone or in combination. 29 Respiratory complaints are also the most frequent reason for over the counter (OTC) purchases of homeopathic medicines, 30 suggesting a demand for alternatives to pharmaceutical OTC products.
Public health and medical stewardship programs aim to alter patients' perceptions and doctors' prescribing behaviour. 1 Yet in many clinical contexts, antibiotic prescribing continues to elude best practice, 1 including in the treatment of URTIs and URTI related conditions. 31, 32, 33 According to a recent US clinical report, up to 10 million antibiotic prescriptions per year directed toward respiratory conditions were unlikely to provide any benefit. 34 Fewer than 10% of sore throats are caused by bacterial infections, yet in around 60% of cases, antibiotics were prescribed for them. 35 In recent Cochrane reviews the short-term effects of antibiotics on acute otitis media (AOM) 36 and URTIs 37 were moderate or negligible when compared to their potential risks. One Cochrane study found antibiotics be 'not very useful' in the treatment of AOM, only marginally decreasing the number of children with pain at 24 hours (when most children were better), only slightly reducing those with pain in the few days following infection and having no effect on reducing the number of children with subsequent hearing loss. 36 In some patients with acute bronchitis, antibiotics had a modest beneficial effect, however these benefits must be considered in the broader context of side effects, the self-limiting nature of the condition, the costs of antibiotic treatment and the increased resistance to respiratory pathogens. 37 Only in the case of pneumonia in the elderly were the benefits of antibiotics seen as significant, 38 however the authors of this study concluded that the use of antibiotics for prophylaxis was still not justifiable. Another US study estimated the number of annual antibiotic prescriptions for acute respiratory conditions (including sinusitis, otitis media, and pharyngitis) as 221 per 1000 people, yet only half of these prescriptions were considered appropriate for these conditions. 39 Understanding differential diagnosis is also important, as is ruling out more serious illness. For instance, while most cases of acute pharyngitis in children have a viral origin, are benign and selflimiting, (and for which antibiotics are often unnecessarily prescribed), untreated streptococcal tonsillopharyngitis can result in serious complications, such as rheumatic fever and related cardiovascular disorders or post streptococcalglomerulonephritis. 40, 41 In addition to efficacy, the immunological effects and safety of antibiotics is a concern.
Studies confirm that pervasive changes occur within the human microbiome after antibiotic treatment and that resistant strains of bacteria can persist for years. 42 Individuals prescribed antibiotics in primary care for a respiratory infection develop bacterial resistant to that antibiotic, which not only increases the population carriage of organisms resistant to first line antibiotics, but leads to increased use of second line antibiotics in the community. 43 According to one meta-analysis, the risk of acquiring methicillin-resistant Staphylococcus aureus increased by 1.8-fold in patients, who had taken antibiotics. 44 Nevertheless, public awareness concerning the appropriate use and safety of antibiotics still appears to be lacking. In one Australian consumer study, over a third of the 252 participants thought that taking antibiotics when suffering from a cold or flu would lead to more rapid recovery, while nearly one-fifth considered antibiotics as a cure for viral infections. 45 Links have been established between antibiotic use and paediatric asthma 46, 47 and eczema 48 and less common but grave physical and psychoactive side effects associated with particular antibiotics. The class of antibiotics fluoroquinolones are known to cause tendonitis, CNS effects, peripheral neuropathy, 49 and juvenile fluoroquinolone-induced joint/cartilage toxicity. 50 Severe side effects of the broad spectrum antibiotic Clarithromycin include liver and renal failure 51, 52 and psychoneurological effects including hallucinations, depersonalization, depression, insomnia and psychosis. 53
The homeopathic approach
As a CAM therapy, homeopathy has been subject to criticism for its use of infinitesimal doses to treat different aliments, with insufficient proof that such doses can have an effect. 54 Yet, despite a long history of scientific controversy, homeopathy has proved resilient, is geographically widespread 55 and is an accepted part of the medical system in countries such as India, 56 France 57 and Switzerland. 58 Advantages of homeopathy include ease of application and safety, with few contraindications existing in the treatment of the very young 28 and old, beside the careful selection of remedy and dosage.
Whereas using antibiotics and over the counter medications does little to improve the body's future response to infection, homeopathy purports to do so.
When dealing with complex systems, a holistic medical approach, such as is frequently used in homeopathy, can offer therapeutic advantages over non-individualised reductionist methods. 59, 60 In part it is the person focused approach of traditional homeopathy that distinguishes it from conventional approaches 61 and contributes to its appeal to certain population groups. [62] [63] [64] Unlike mainstream medicine, where treatment is based on the clinical diagnosis and the idiosyncratic symptoms of the patient are given less importance, in the 'classical' homeopathic tradition the prescription of a homeopathic medication or 'remedy' is based on the totality of symptoms and signs exhibited or expressed by an individual patient. 65 Thus in homeopathic case-taking the assessment of the medical situation may not be the principle reason for the choice of remedy 58 and a spectrum of remedies based on different criteria may be considered.
There are, however, many variations to the homeopathic method of prescribing, especially in the treatment of chronic conditions. A particular distinction lies between individualised and clinically based homeopathic treatment protocols, the former being based on a 'total system approach' as described above and the latter on a more generic method, in which 'combination' or 'complex' homeopathic medicines may be prescribed for a particular condition or disease. 66 Another method, 'isopathy,' refers to the use of diseased byproducts or tissues known as 'nosodes,' and healthy animal tissue, referred to as sarcodes, 67 which may be prescribed individually or to a population group for preventative purposes. 68, 69 All of these methodologies have been employed in clinical studies, including for the treatment of UTRIs. From the homeopathic perspective, patients with chronic conditions may require 'constitutional' remedies, emphasising the suitability of the in depth individualised approach. Seeking a 'totality' of symptoms in a holistic sense 70 is resource and time consuming however, as it requires a detailed chronological history of the patient and their condition so that a single remedy can be prescribed to treat a range of symptoms. In acute conditions the symptom picture is less complicated and the need to prescribe more urgent, strengthening the case for non-individualised prescribing.
Homeopathy and research
With an empirical tradition going back more than 200 years, and homeopathic physicians trained in the scientific method, research has always been the backbone of homeopathy.
Homeopathic literature includes as a vast number of published drug 'provings,' case studies and practice reports, however substantial areas of practice have remained uncharted, for instance the treatment of large-scale epidemics have never been systematically and scientifically researched. 58 The problems of measuring the effects of homeopathic treatment through randomised controlled trials (RCTs) and other reductionist methods are considerable. A number of systematic reviews of the homeopathy RCT literature by Mathie et al 66, 71, 72 found significant inadequacies, with the majority of studies demonstrating uncertain or high risk of bias. Some studies were not properly randomise, with most studies addressing a different aspect of homeopathic care. 73 Practical problems of RCTs include selecting patients for participation, the insecurities caused by blinding and variations in the level of training of individual homeopathic physicians. Whereas conventional medicine examines the specific effect of a pharmaceutical substance, the effects of a homeopathic substance arise from its complex individual interaction with the organism and this limits the external validity and generalizability of placebo-controlled, blinded homeopathy studies. 58 As with all clinical trials, there are variations in size and outcome measures with the limited number of homeopathic studies making these types of anomaly more significant.
The absence of positive or any RCT results does not necessarily mean that a treatment is ineffective, and a danger lies in eliminating treatments on the basis of no RCT proof of their efficacy. 58 Non-randomised controlled trials and patient reported surveys are considered by some to be inferior forms of research evidence, but are important adjuncts to RCTs which can measure key markers such as patient satisfaction, quality of life and functional health. Observational studies such as clinical outcome studies and case reports, monitoring the effects of homeopathy in real-life clinical settings, are a helpful adjunct to randomised controlled trials 74 and more closely reflect real life experiences of patients and physicians than RCTs, 75 and are therefore considered in this study.
Results
Searches of online libraries and bibliographical references found multiple peer review studies (in English and non-English) published between 1994 and 2017, in which homeopathy had been used to treat upper respiratory tract infections and associated symptoms (cough, pharyngitis, tonsillitis, otitis media, acute sinusitis etc.). Both randomised control trials (RCTs) and observational/cohort studies were searched and screened to ensure that, as many studies as possible were included in the review and its discussion. Non-English language studies, and those for which key study details could not be established, were later excluded from the final review, as were those that did not directly refer to UTRIs in the title or content. For the final review, 9 RCTs and 8 observational/ cohort studies were analysed, of which 6 of the RCTs and one observational/ cohort trial were paediatric studies. 7 RCTs used combination remedies with multiple constituents. One of RCTs in these tables is featured twice as it measured treatment effects on two different cohorts. The first paper (Thinesse-Mallwitz et al (2015)) 76 Full details of randomised and observational studies including trial design, mode of homeopathic treatment (e.g. complex, individualised), cohort, outcome assessment, results and conclusions are given on table 1. Table 2 focuses on studies using complex homeopathic remedies, and a breakdown of the homeopathic constituents where this information was available.
Insert tables here:
The paper's discussion focuses on the following areas of concern: extent to which homeopathy is used for URTIs; tolerability and rate of improvement of homeopathic treatment; complications of URTIs; prophylactic and long-term effects; the use of combination versus single homeopathic remedies. As a literature review, rather than a systematic review, no attempt has been made to extract new data from the primary papers, or to assess the intrinsic quality of each study, including risk of bias.
Use of Homeopathy for UTRIs
Respiratory infections are a common reason for seeking homeopathic care. 78, 79 For example, out of 551 paediatric patients treated at a homeopathic clinic in Rossi et al's (2010) observational study, 337 presented (61%) presented with respiratory infections, making this the most frequently observed disease in this population group. 80 Of the various clinical trials featuring the use of homeopathy for a specific condition, those concerning infectious diseases of the upper respiratory tract, 13, 29, 81, 82 
Tolerability
In the treatment of self-limiting acute conditions such URTIs and mild infections, both treatment tolerability and the rate of improvement with a medical intervention are important and a number of studies suggest that homeopathic treatment can fulfil both these prerequisites. Many participants in homeopathic studies are children 9,81,83-87 so it is significant that the safety and tolerability of homeopathic treatment in the trials reviewed was very good. 29, 76, 81, 88 A good rate of improvement in the acute symptoms of URTI in those receiving homeopathic treatment was reported in all the RCTs and observational trials in which this was measured, however the timescale for symptom improvement varied, for example fever 29 improved/ resolved faster than cough. 13 In Rabe et al's (2004) study, treatment with the homeopathic remedy complex Gripp-Heel was perceived by patients with mild viral infections to be more successful, with greater tolerability and compliance than conventional treatment. 67.9% of patients were considered by physicians to be asymptomatic at the end of Gripp-Heel therapy, compared to 47.9% in the control group. 89 Results at 14 days were similar in both groups. The authors concluded that homeopathy was not inferior to conventional treatment in ear and acute respiratory infections.
Complications of URTIs
Complications of URTIs are not the primary focus of this paper, however in clinical practice they remain the most common causes of antibiotic prescriptions 21, 91, 39 and as such warrant some attention in this review. Searches revealed a good number of studies in which homeopathy had been used for the URTI related disorders with promising outcomes, including acute otitis media (ear infections) 9, 83, 92, 93 , rhinopharyngitis, 94, 95 sinusitis, 96, 97, 98, 99 and tonsillitis. 100, 101 In a study by Trichard et al (2004) comparing homeopathic and antibiotic treatment strategies for rhinopharyngitis in children, homeopathy yielded significantly better results than antibiotics in terms of both medical effectiveness (reduced number of episodes and number of complications) and improved quality of life with significantly less time taken off work for parents. 94 A randomised, double-blind study by Friese and Zabalotnyi (2007) 96 investigated the efficacy and tolerability of a homeopathic combination remedy for the treatment of acute rhinosinusitis. 144 patients with acute rhinosinusitis were treated either with a homeopathic remedy (n=72) or placebo (n=72). In the treatment group, the average sum score dropped from initially 12.1+/-1.6 to 5.9+/-2.0 points after 7 days. In the placebo group it decreased from 11.7+/-1.6 to 11.0+/-2.9 points (p<0.0001). After 21 days, 90.3% of the homeopathic treatment group were free from complaints, whereas in 88.9% of the placebo group the complaints remained unchanged or became worse. The authors concluded that the homeopathic product allowed an effective and tolerable treatment of acute rhinosinusitis.
There have been several studies indicating the effectiveness of homeopathy for both acute and chronic tonsilopharangitis. Friese et al. 102 Typical tonsillitis symptoms included swallowing difficulties, throat pain and redness, salivation and fever. By day 4, the study group showed a significantly higher rate of decrease in symptoms and than the placebo group. By day 6, 92.4% of study patients showed full recovery or moderate improvement, compared to the 43.1 % in the control group, with a deterioration rate of 3.8% in the study group against 22.8% in the control group.
A more recent international randomised, controlled, clinical trial of the homeopathic combination remedy SilAtro-5-90 (brand name Tonsilotren®) was carried out in multiple settings by Palm et al (2017) . 101 256 patients aged 6-60 years with moderate recurrent tonsillitis (RT) were given either the homeopathic preparation in addition to standard symptomatic treatment, or standard treatment alone. The test group received Tonsilotren® for 3 treatment periods of 8 weeks, each treatment period being followed by an 8 to 12 weeks period without the homeopathic preparation. The primary outcome measure was the estimated rate of diagnosed acute throat infections per year with other outcome measures being severity of RT symptoms and the antibiotics required due to acute throat infections. Occurrence of RT symptoms was seen in a significantly lower percentage of patients in the test group compared to the control group. There was also a reduction in antibiotics used due to acute throat infections. The authors conclude that an integrative treatment approach in which SilAtro-5-90 or Tonsilotren® is given alongside mainstream symptomatic treatment could be of therapeutic benefit to patients with a history of RT.
Both small and large-scale studies suggest that homeopathy may reduce the prescribing of antibiotics for acute URTIs and their sequelae. 29, 85, 103, 104 
Prophylactic and long term effects
CAM therapies that are proven safe can be used to strengthen the self-healing capacities of the organism (preventive and curative health promotion). 105 Hospital Outcome Score (GHHOS) was used to assess outcome. After homeopathic treatment, 68% of children with respiratory disease showed a strong improvement or attained a resolution of their problems. They conclude that improvement or resolution of symptoms is more likely in patients with problems in the upper respiratory tract than other categories (e.g. dermatological, digestion psychological) and in patients followed up for at least 12 months.
Another observational study by Witt et al (2009) 99 showed long term improvements in patients seeking homeopathic treatment for sinusitis. The treatment group (a subgroup of a large multi-centred observational study) included 134 adults treated by 62 physicians.
All patients had suffered from chronic sinusitis for over 9 years almost all (97.0%) of who had previously been treated with conventional medicine. Self-reported scores showed both physical and mental improvements persisting for 8 years. The authors point to the need for more explanatory studies to establish the extent to which these effects could be due to life-style regulation, placebo, or context effects associated with the treatment. Also of interest is a multicentre observational study carried out in India by Nayak et al (2012) 97 which sought to test the therapeutic usefulness of homeopathic medicine in the management of chronic sinusitis (CS) on 550 patients. The chronic sinusitis assessment score (CSAS) was used to assess symptom severity. The authors of this study found statistically significant reductions in CSAS after 3 and 6 months of treatment, along with improved radiological appearance. No complications were observed during treatment. Their conclusion is that homeopathic treatment could be effective for CS patients but controlled trials were required for further validation.
Combination versus single homeopathic remedies
The studies featured in this review adopt a range of approaches to prescribing, both from the perspective of control and selection of single or combination remedies with varying constituents (see table 2 Homeopathic compounds and syrups contained up to nine different constituents, generally in low potencies. 76, 81, [106] [107] [108] Despite wide variations in the remedies chosen, some clear 'favourites' emerged, the most commonly used remedies being Bryonia (6 studies), Phosphorus (4 studies), Ipecachuana (4 studies) and Sulphur (3 studies).
The findings from this review suggest at least equivalence between complex homeopathy and conventional treatment for uncomplicated cases of URTI. In all but one study, the homeopathic products under evaluation yielded favourable results by way of milder symptoms and shorter duration of acute illness, and several had led to reduced use of antibiotics. Given the ease and convenience of this type of prescribing, the distress associated with acute URTIs, 102 the need to reduce reliance on antibiotics and the known side effects of pharmaceutical OTC products, there is a case for using tried and tested combination remedies to treat uncomplicated cases of URTIs. On the other hand, the quality of the body of evidence on non-individualised homeopathic treatment is low, and the risk of bias in existing RCTs is high. 66 The variable constituents of each product (some of which contained 8 or more homeopathic ingredients) call into question the specific action of these products on URTIs, especially given the short lived nature of this condition in otherwise healthy children and adults. In addition, some products such as Engystol® have been tested in several studies with different results. 66, 88, 109 It is important that combination remedies continue to be subject to rigorous trials, which test the efficacy and safety of such compounds. 29, 76, 81 Dose frequency and duration of use also need to be considered to eliminate accidental provings or remedy 'exhaustion'. 1 Acute illnesses produce different symptoms in patients, and more research is required to establish which products suit particular scenarios and at which stage of illness they are most effective.
Mathie et al's recently published paper suggests that the model validity of placebocontrolled trials of non-individualised homeopathic treatment is lower than that of individualised treatment. 110 In a follow up paper, the authors conclude that better designed and more rigorous RCTs are needed in order to develop an evidence base that can decisively provide reliable effect estimates of non-individualised homeopathic treatment 66 , however neither individualised nor non-individualised RCT trials featuring homeopathy score highly in terms of risk of model validity and risk of bias.
Conclusions
With the emergence of AMR, respiratory infections have become more difficult to treat.
Inappropriate use of antibiotics and other antimicrobials leads to the growth and spread of resistant bacteria, which colonise the airways and can affect the entire community. 91 The push to limit AMR requires a consolidated, concerted effort by multiple stakeholders. 111 Effective strategies are needed to restrict the use of antibiotics without harming those who truly need these medications. While life style and nutrition play a significant part in their control, homeopathy presents a low cost, holistic adjunct or alternative for many common infections. The clinical trials examined in this paper showed variations in size, location, cohort types, type of intervention and outcome measures, which makes comparisons and generalisations problematic. Nevertheless, combined evidence from these and other studies suggest that homeopathic treatment can exert biological effects with fewer adverse events and broader therapeutic opportunities than conventional medicine in the treatment of URTIs. 58, 112 Given the cost implications of treating UTRIs and their complications in children, and the relative absence of effective alternatives without potential side effects, the use of non-individualised homeopathic compounds tailored for the pediatric population merits further investigation, including through larger scale cohort studies.
The quantity of peer reviewed homeopathic research is small when compared to conventional medicinal research. There are many gaps in evidence, but recent studies support the view that homeopathy could be at least as effective as a standard treatment, with effects which can be differentiated from placebo 113, 114 and can fill existing effectiveness gaps in the conventional medical treatment of URTIs and their complications. 9 Importantly for global health, studies such as those presented in this paper suggest that patients given homeopathic treatment and who follow sensible disease avoidance measures, may avoid infections, or may be able to reduce reliance on conventional medication, including antibiotics. 9, 95 . In the meantime, the most important evidence still arises from practical clinical experience and from the successful treatment of millions of patients.
With the advent of antimicrobial resistance, homeopathy would appear to have a role to play both in offering alternative treatment for URTIs, and the possibility of the prevention of recurring infections associated with the upper respiratory tract. Further research is required to establish the best means of achieving this, however prioritizing studies of pediatric and elderly populations would seem a path forward for the reduction of antibiotic use and the on-going risk of resistance.
